Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan

Szu‐Jen Wang(Kaohsiung Medical University), Ming‐Lung Yu(National Sun Yat-sen University)
The Kaohsiung Journal of Medical Sciences
June 20, 2025
10.1002/kjm2.70067
Cited by 0

Related Papers

Treatment of chronic hepatitis C in Asia: When East meets West
|Journal of Gastroenterology and Hepatology|2009|262
Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy
|Scientific Reports|2015|62
Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase
|Oncotarget|2017|40